Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A V Ciaccia

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Protein Expression and Purification|December 1, 1995
Characterization of recombinant heparin cofactor II expressed in insect cellsA V Ciaccia, E L Cunningham, F C Church
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Selective estrogen receptor modulators: tissue selectivity and differential uterine effectsS L Silfen, A V Ciaccia, H U Bryant
The Journal of Biological Chemistry|May 30, 1997
Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibitionA V Ciaccia, D M Monroe, F C Church
The Journal of Biological Chemistry|January 10, 1997
Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor IIA V Ciaccia, A J Willemze, F C Church
Human Reproduction Update|June 30, 2000
A pharmacological review of selective oestrogen receptor modulatorsS R Goldstein, S Siddhanti, A V Ciaccia, et al.
Cleveland Clinic Journal of Medicine|April 26, 2000
Raloxifene: a new choice for treating and preventing osteoporosisA A Licata, A V Ciaccia, M Wong, et al.
Obstetrics and Gynecology|June 30, 2001
Raloxifene effect on frequency of surgery for pelvic floor relaxationS R Goldstein, P Neven, L Zhou, et al.
Endocrinology|October 3, 2000
17beta-estradiol, but not raloxifene, decreases thrombomodulin in the antithrombotic protein C pathwayM A Richardson, D T Berg, D S Calnek, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Protein Expression and Purification|December 1, 1995
Characterization of recombinant heparin cofactor II expressed in insect cellsA V Ciaccia, E L Cunningham, F C Church
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Selective estrogen receptor modulators: tissue selectivity and differential uterine effectsS L Silfen, A V Ciaccia, H U Bryant
The Journal of Biological Chemistry|May 30, 1997
Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibitionA V Ciaccia, D M Monroe, F C Church
The Journal of Biological Chemistry|January 10, 1997
Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor IIA V Ciaccia, A J Willemze, F C Church
Human Reproduction Update|June 30, 2000
A pharmacological review of selective oestrogen receptor modulatorsS R Goldstein, S Siddhanti, A V Ciaccia, et al.
Cleveland Clinic Journal of Medicine|April 26, 2000
Raloxifene: a new choice for treating and preventing osteoporosisA A Licata, A V Ciaccia, M Wong, et al.
Obstetrics and Gynecology|June 30, 2001
Raloxifene effect on frequency of surgery for pelvic floor relaxationS R Goldstein, P Neven, L Zhou, et al.
Endocrinology|October 3, 2000
17beta-estradiol, but not raloxifene, decreases thrombomodulin in the antithrombotic protein C pathwayM A Richardson, D T Berg, D S Calnek, et al.
Pageof 1